en
Scientific article
English

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis

Published inJournal of Crohn's and colitis, vol. 8, no. 8, p. 825-834
Publication date2014
Abstract

Anti-TNFα agents are commonly used for ulcerative colitis (UC) therapy in the event of non-response to conventional strategies or as colon-salvaging therapy. The objectives were to assess the appropriateness of biological therapies for UC patients and to study treatment discontinuation over time, according to appropriateness of treatment, as a measure of outcome.

Keywords
  • Adolescent
  • Adult
  • Aged
  • Colitis, Ulcerative/drug therapy
  • Female
  • Humans
  • Immunologic Factors/adverse effects/therapeutic use
  • Inappropriate Prescribing/statistics & numerical data
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors
  • Young Adult
Citation (ISO format)
MAILLARD, Michel H et al. Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis. In: Journal of Crohn’s and colitis, 2014, vol. 8, n° 8, p. 825–834. doi: 10.1016/j.crohns.2013.12.026
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1873-9946
498views
0downloads

Technical informations

Creation26/08/2015 14:06:00
First validation26/08/2015 14:06:00
Update time14/03/2023 23:35:15
Status update14/03/2023 23:35:14
Last indexation16/01/2024 18:49:33
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack